Contact your Member of Congress to Push Back Against CMS' Step Therapy Policy
In August, the Centers for Medicare and Medicaid Services (CMS) announced that Medicare Advantage plans will be able to apply step therapy to Part B drugs, effective January 1, 2019. Step therapy, or “fail first,” requires patients to try the drug preferred by their insurance company before they can proceed to the drug prescribed by their physician. If MA plans choose to apply step therapy to cancer drugs, this could have a devastating impact on patients.
